As of 2026-01-03, the Relative Valuation of Cue Biopharma Inc (CUE) is (8.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.34 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -2646.1%.
The range of the Relative Valuation is (6.93) - (9.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 19.3x | 17.8x |
| Forward P/E multiples | 14.5x - 21.7x | 18.1x |
| Fair Price | (6.93) - (9.23) | (8.59) |
| Upside | -2153.9% - -2834.7% | -2646.1% |
| Date | P/E |
| 2025-12-31 | -0.64 |
| 2025-12-30 | -0.63 |
| 2025-12-29 | -0.58 |
| 2025-12-26 | -0.68 |
| 2025-12-24 | -0.50 |
| 2025-12-23 | -0.51 |
| 2025-12-22 | -0.53 |
| 2025-12-19 | -0.56 |
| 2025-12-18 | -0.71 |
| 2025-12-17 | -0.84 |
| 2025-12-16 | -0.86 |
| 2025-12-15 | -0.97 |
| 2025-12-12 | -1.02 |
| 2025-12-11 | -1.03 |
| 2025-12-10 | -1.00 |
| 2025-12-09 | -1.03 |
| 2025-12-08 | -1.10 |
| 2025-12-05 | -1.15 |
| 2025-12-04 | -1.16 |
| 2025-12-03 | -1.17 |
| 2025-12-02 | -1.19 |
| 2025-12-01 | -1.24 |
| 2025-11-28 | -1.32 |
| 2025-11-26 | -1.31 |
| 2025-11-25 | -1.27 |
| 2025-11-24 | -1.23 |
| 2025-11-21 | -1.24 |
| 2025-11-20 | -1.13 |
| 2025-11-19 | -1.21 |
| 2025-11-18 | -1.21 |
| 2025-11-17 | -1.20 |
| 2025-11-14 | -1.32 |
| 2025-11-13 | -1.29 |
| 2025-11-12 | -1.39 |
| 2025-11-11 | -1.43 |
| 2025-11-10 | -1.42 |
| 2025-11-07 | -1.47 |
| 2025-11-06 | -1.50 |
| 2025-11-05 | -1.53 |
| 2025-11-04 | -1.51 |
| 2025-11-03 | -1.50 |
| 2025-10-31 | -1.60 |
| 2025-10-30 | -1.46 |
| 2025-10-29 | -1.44 |
| 2025-10-28 | -1.54 |
| 2025-10-27 | -1.61 |
| 2025-10-24 | -1.64 |
| 2025-10-23 | -1.63 |
| 2025-10-22 | -1.60 |
| 2025-10-21 | -1.72 |